(Q46661443)

24 December 2017

title

Atorvastatin does not improve liver biochemistries or Mayo Risk Score in primary biliary cirrhosis (English)

1 reference

24 December 2017

primary biliary cholangitis

main subject

liver cirrhosis

0 references

0 references

4

Carol Bodian

1 reference

24 December 2017

author name string

Carmen M Stanca

1

1 reference

24 December 2017

Nancy Bach

2

1 reference

24 December 2017

Jorge Allina

3

1 reference

24 December 2017

Henry Bodenheimer

5

1 reference

24 December 2017

Joseph A Odin

6

1 reference

24 December 2017

publication date

5 April 2008

1 reference

24 December 2017

Digestive Diseases and Sciences

published in

1 reference

24 December 2017

volume

53

1 reference

24 December 2017

issue

7

1 reference

24 December 2017

page(s)

1988-1993

1 reference

24 December 2017

https://scigraph.springernature.com/pub.10.1007/s10620-007-0003-2

exact match

0 references

cites work

Current perspectives on statins

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10620-007-0003-2

Validation of a fatigue impact score in primary biliary cirrhosis: towards a standard for clinical and trial use.

21 January 2018

1 reference

12 December 2020

Lipoprotein abnormalities in primary biliary cirrhosis. Association with hepatic lipase inhibition as well as altered cholesterol esterification.

1 reference

12 December 2020

Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines

1 reference

12 December 2020

Primary biliary cirrhosis: prediction of short-term survival based on repeated patient visits

1 reference

12 December 2020

Primary biliary cirrhosis, hyperlipidemia, and atherosclerotic risk: a systematic review

1 reference

12 December 2020

Cyclosporin A treatment in primary biliary cirrhosis: results of a long-term placebo controlled trial

1 reference

12 December 2020

Lipoprotein abnormalities in patients with early primary biliary cirrhosis

1 reference

12 December 2020

Evaluation of fatigue in U.S. patients with primary biliary cirrhosis.

1 reference

12 December 2020

Low-dose methotrexate is ineffective in primary biliary cirrhosis: long-term results of a placebo-controlled trial

1 reference

12 December 2020

Effects of HMG-CoA reductase inhibitors on skeletal muscle: are all statins the same?

1 reference

12 December 2020

A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results

1 reference

12 December 2020

Hepatotoxicity of hypolipidemic drugs

1 reference

12 December 2020

The true impact of fatigue in primary biliary cirrhosis: a population study

1 reference

12 December 2020

Simvastatin in primary biliary cirrhosis: effects on serum lipids and distinct disease markers

1 reference

12 December 2020

Four year follow up of fatigue in a geographically defined primary biliary cirrhosis patient cohort

1 reference

12 December 2020

Reliability and validity of the NIDDK-QA instrument in the assessment of quality of life in ambulatory patients with cholestatic liver disease.

1 reference

12 December 2020

Experience with statin use in patients with chronic hepatitis C infection

1 reference

12 December 2020

Primary biliary cirrhosis

1 reference

12 December 2020

Atorvastatin associated liver disease

1 reference

12 December 2020

Hypercholesterolaemia is not associated with early atherosclerotic lesions in primary biliary cirrhosis

1 reference

12 December 2020

Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis

1 reference

12 December 2020

Marked improvement in cholestasis and hypercholesterolemia with simvastatin in a patient with primary biliary cirrhosis

1 reference

12 December 2020

Hypercholesterolemia in primary biliary cirrhosis is no risk factor for atherosclerosis

1 reference

12 December 2020

Statins as a newly recognized type of immunomodulator

1 reference

12 December 2020

Hypercholesterolemia and atherosclerosis in primary biliary cirrhosis: what is the risk?

1 reference

12 December 2020

Experimental use of pravastatin in patients with primary biliary cirrhosis associated with hypercholesterolemia

1 reference

12 December 2020

Incidence of statin hepatotoxicity in patients with hepatitis C.

1 reference

12 December 2020

Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: a histopathological follow-up study

1 reference

12 December 2020

Efficacy of liver transplantation in patients with primary biliary cirrhosis

1 reference

12 December 2020

The histologic effects of low-dose methotrexate therapy for primary biliary cirrhosis

1 reference

12 December 2020

Safety and tolerability of pravastatin in long-term clinical trials: prospective Pravastatin Pooling (PPP) Project

1 reference

12 December 2020

Serum 27-hydroxycholesterol in patients with primary biliary cirrhosis suggests alteration of cholesterol catabolism to bile acids via the acidic pathway

1 reference

12 December 2020

Effect of pravastatin on outcomes after cardiac transplantation.

1 reference

12 December 2020

Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial

1 reference

12 December 2020

10.1007/S10620-007-0003-2

Identifiers

DOI

1 reference

24 December 2017

1 reference

24 December 2017